PENTAX Medical Announces Sale of C2 CryoBalloon™ Product Line to Merit Medical Systems through Asset Purchase Agreement

PENTAX Medical Announces Sale of C2 CryoBalloon™ Product Line to Merit Medical Systems through Asset Purchase Agreement

Merit Medical to acquire Pentax Medical's C2 CryoBalloon technology - Interventional News

Pentax Medical has today announced an asset purchase agreement with Merit Medical Systems for the acquisition of the C2 CryoBalloon technology. The C2 CryoBalloon has been part of Pentax Medical’s therapeutic portfolio since 2017, offering a minimally invasive option to treat patients suffering from Barrett’s Esophagus and other gastrointestinal disorders. The minimally invasive device delivers controlled cryotherapy to ablate unwanted tissue wh…

Merit Medical to acquire C2 CryoBalloon assets from Pentax of America

Merit Medical Systems has entered into a definitive agreement for the acquisition of the C2 CryoBalloon device and its associated technology.The post Merit Medical to acquire C2 CryoBalloon assets from Pentax of America appeared first on Medical Device Network.

PENTAX Medical 2025: C2 CryoBalloon Line Sold to Merit Medical

MONTVALE, N.J., Oct. 16, 2025 /PRNewswire/ -- PENTAX Medical, a division of HOYA Group and a global leader in flexible reusable endoscopy, today announced an asset purchase agreement with Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, for the acquisition of the C2 CryoBalloon™ technology. This strategic move allows PENTAX Medical to sharpen its focus on core endoscopic solutions while fostering deeper clini…